Annual CFO
-$99.15 M
-$34.46 M-53.28%
31 December 2021
Summary:
Aerie Pharmaceuticals annual cash flow from operations is currently -$99.15 million, with the most recent change of -$34.46 million (-53.28%) on 31 December 2021. During the last 3 years, it has fallen by -$34.46 million (-53.28%).AERI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$11.40 M
+$1.83 M+13.84%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly cash flow from operations is currently -$11.40 million, with the most recent change of +$1.83 million (+13.84%) on 30 September 2022.AERI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$7.17 M
+$7.45 M+2641.49%
30 September 2022
Summary:
Aerie Pharmaceuticals TTM cash flow from operations is currently $7.17 million, with the most recent change of +$7.45 million (+2641.49%) on 30 September 2022.AERI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -53.3% | +39.5% | +115.3% |
| 5 y5 years | +35.0% | +70.2% | +104.6% |
AERI Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +726.4% | -118.4% | at high |
Aerie Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$11.40 M(-13.8%) | $7.17 M(-2641.5%) |
| June 2022 | - | -$13.23 M(-121.4%) | -$282.00 K(-96.1%) |
| Mar 2022 | - | $61.91 M(-305.6%) | -$7.19 M(-92.7%) |
| Dec 2021 | -$99.15 M(+53.3%) | -$30.11 M(+59.7%) | -$99.15 M(+112.4%) |
| Sept 2021 | - | -$18.85 M(-6.4%) | -$46.68 M(-7.0%) |
| June 2021 | - | -$20.14 M(-33.0%) | -$50.19 M(-5.2%) |
| Mar 2021 | - | -$30.05 M(-234.4%) | -$52.92 M(-18.2%) |
| Dec 2020 | -$64.69 M(-57.0%) | $22.36 M(-200.0%) | -$64.69 M(-43.3%) |
| Sept 2020 | - | -$22.36 M(-2.2%) | -$114.18 M(-12.2%) |
| June 2020 | - | -$22.87 M(-45.3%) | -$130.01 M(-9.5%) |
| Mar 2020 | - | -$41.82 M(+54.2%) | -$143.61 M(-4.5%) |
| Dec 2019 | -$150.43 M(-1.4%) | -$27.12 M(-29.0%) | -$150.43 M(-2.8%) |
| Sept 2019 | - | -$38.20 M(+4.7%) | -$154.82 M(-3.2%) |
| June 2019 | - | -$36.47 M(-25.0%) | -$159.89 M(-0.3%) |
| Mar 2019 | - | -$48.64 M(+54.3%) | -$160.38 M(+5.1%) |
| Dec 2018 | -$152.58 M(+63.7%) | -$31.51 M(-27.2%) | -$152.58 M(+3.6%) |
| Sept 2018 | - | -$43.26 M(+17.0%) | -$147.21 M(+17.6%) |
| June 2018 | - | -$36.96 M(-9.5%) | -$125.23 M(+14.7%) |
| Mar 2018 | - | -$40.84 M(+56.2%) | -$109.19 M(+17.1%) |
| Dec 2017 | -$93.21 M | -$26.15 M(+22.9%) | -$93.21 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$21.28 M(+1.6%) | -$85.91 M(+0.1%) |
| June 2017 | - | -$20.93 M(-15.8%) | -$85.79 M(+0.5%) |
| Mar 2017 | - | -$24.85 M(+31.9%) | -$85.34 M(+6.9%) |
| Dec 2016 | -$79.84 M(+43.2%) | -$18.85 M(-10.9%) | -$79.84 M(+6.1%) |
| Sept 2016 | - | -$21.16 M(+3.4%) | -$75.23 M(+14.0%) |
| June 2016 | - | -$20.47 M(+5.8%) | -$65.99 M(+6.8%) |
| Mar 2016 | - | -$19.36 M(+36.0%) | -$61.80 M(+10.9%) |
| Dec 2015 | -$55.75 M(+65.3%) | -$14.23 M(+19.4%) | -$55.75 M(+5.5%) |
| Sept 2015 | - | -$11.92 M(-26.8%) | -$52.84 M(+4.9%) |
| June 2015 | - | -$16.28 M(+22.3%) | -$50.39 M(+18.5%) |
| Mar 2015 | - | -$13.31 M(+17.4%) | -$42.54 M(+26.1%) |
| Dec 2014 | -$33.73 M(+105.0%) | -$11.33 M(+19.7%) | -$33.73 M(+23.7%) |
| Sept 2014 | - | -$9.47 M(+12.4%) | -$27.27 M(+25.2%) |
| June 2014 | - | -$8.42 M(+87.3%) | -$21.79 M(+17.4%) |
| Mar 2014 | - | -$4.50 M(-7.9%) | -$18.57 M(+12.9%) |
| Dec 2013 | -$16.45 M(+9.9%) | -$4.88 M(+22.4%) | -$16.45 M(+42.2%) |
| Sept 2013 | - | -$3.99 M(-23.3%) | -$11.57 M(+52.6%) |
| June 2013 | - | -$5.20 M(+118.5%) | -$7.58 M(+218.5%) |
| Mar 2013 | - | -$2.38 M | -$2.38 M |
| Dec 2012 | -$14.97 M(+24.8%) | - | - |
| Dec 2011 | -$12.00 M | - | - |
FAQ
- What is Aerie Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual cash flow from operations?
The current annual CFO of AERI is -$99.15 M
What is the all time high annual CFO for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual cash flow from operations is -$12.00 M
What is Aerie Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AERI is -$11.40 M
What is the all time high quarterly CFO for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly cash flow from operations is $61.91 M
What is Aerie Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AERI is $7.17 M
What is the all time high TTM CFO for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM cash flow from operations is $7.17 M